nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—Goserelin—breast cancer	0.615	1	CrCtD
Icatibant—Gonadorelin—Goserelin—breast cancer	0.243	1	CrCrCtD
Icatibant—ANPEP—mammary gland—breast cancer	0.00278	0.082	CbGeAlD
Icatibant—ANPEP—nipple—breast cancer	0.0023	0.0678	CbGeAlD
Icatibant—BDKRB2—endometrium—breast cancer	0.00223	0.0657	CbGeAlD
Icatibant—BDKRB2—uterus—breast cancer	0.00205	0.0605	CbGeAlD
Icatibant—BDKRB2—adipose tissue—breast cancer	0.00201	0.0592	CbGeAlD
Icatibant—ANPEP—embryo—breast cancer	0.0019	0.0559	CbGeAlD
Icatibant—BDKRB2—female reproductive system—breast cancer	0.00185	0.0544	CbGeAlD
Icatibant—BDKRB2—adrenal gland—breast cancer	0.0018	0.0531	CbGeAlD
Icatibant—BDKRB2—female gonad—breast cancer	0.00168	0.0495	CbGeAlD
Icatibant—ANPEP—epithelium—breast cancer	0.00155	0.0457	CbGeAlD
Icatibant—ANPEP—skin of body—breast cancer	0.00147	0.0434	CbGeAlD
Icatibant—ANPEP—endometrium—breast cancer	0.00139	0.0409	CbGeAlD
Icatibant—ANPEP—uterus—breast cancer	0.00128	0.0377	CbGeAlD
Icatibant—ANPEP—pituitary gland—breast cancer	0.00126	0.037	CbGeAlD
Icatibant—ANPEP—adipose tissue—breast cancer	0.00125	0.0369	CbGeAlD
Icatibant—ANPEP—female reproductive system—breast cancer	0.00115	0.0339	CbGeAlD
Icatibant—Injection site reaction—Fulvestrant—breast cancer	0.00114	0.0309	CcSEcCtD
Icatibant—ANPEP—adrenal gland—breast cancer	0.00112	0.0331	CbGeAlD
Icatibant—ANPEP—bone marrow—breast cancer	0.00109	0.032	CbGeAlD
Icatibant—BDKRB2—lymph node—breast cancer	0.00108	0.0318	CbGeAlD
Icatibant—ANPEP—female gonad—breast cancer	0.00105	0.0309	CbGeAlD
Icatibant—ANPEP—endocrine gland—breast cancer	0.000975	0.0287	CbGeAlD
Icatibant—ANPEP—lymph node—breast cancer	0.000674	0.0198	CbGeAlD
Icatibant—Anaphylactic shock—Fluoxymesterone—breast cancer	0.000629	0.017	CcSEcCtD
Icatibant—Injection site reaction—Melphalan—breast cancer	0.000592	0.016	CcSEcCtD
Icatibant—Injection site reaction—Goserelin—breast cancer	0.000577	0.0156	CcSEcCtD
Icatibant—Injection site reaction—Vinorelbine—breast cancer	0.000517	0.014	CcSEcCtD
Icatibant—Hypersensitivity—Fluoxymesterone—breast cancer	0.000464	0.0125	CcSEcCtD
Icatibant—Anaphylactic shock—Lapatinib—breast cancer	0.000447	0.0121	CcSEcCtD
Icatibant—Nervous system disorder—Lapatinib—breast cancer	0.000438	0.0118	CcSEcCtD
Icatibant—Injection site reaction—Gemcitabine—breast cancer	0.000415	0.0112	CcSEcCtD
Icatibant—Nervous system disorder—Fulvestrant—breast cancer	0.000403	0.0109	CcSEcCtD
Icatibant—Nervous system disorder—Toremifene—breast cancer	0.000398	0.0107	CcSEcCtD
Icatibant—Headache—Fluoxymesterone—breast cancer	0.000394	0.0106	CcSEcCtD
Icatibant—Body temperature increased—Carboplatin—breast cancer	0.000374	0.0101	CcSEcCtD
Icatibant—Nausea—Fluoxymesterone—breast cancer	0.000374	0.0101	CcSEcCtD
Icatibant—Nervous system disorder—Exemestane—breast cancer	0.00035	0.00944	CcSEcCtD
Icatibant—Injection site reaction—Paclitaxel—breast cancer	0.000348	0.00938	CcSEcCtD
Icatibant—Nervous system disorder—Ixabepilone—breast cancer	0.00033	0.00891	CcSEcCtD
Icatibant—Hypersensitivity—Lapatinib—breast cancer	0.000329	0.00888	CcSEcCtD
Icatibant—Body temperature increased—Fulvestrant—breast cancer	0.000325	0.00876	CcSEcCtD
Icatibant—Anaphylactic shock—Anastrozole—breast cancer	0.000317	0.00855	CcSEcCtD
Icatibant—Anaphylactic shock—Letrozole—breast cancer	0.000317	0.00855	CcSEcCtD
Icatibant—Nervous system disorder—Letrozole—breast cancer	0.000311	0.00839	CcSEcCtD
Icatibant—Hypersensitivity—Fulvestrant—breast cancer	0.000303	0.00816	CcSEcCtD
Icatibant—Anaphylactic shock—Idarubicin—breast cancer	0.000301	0.00812	CcSEcCtD
Icatibant—Nervous system disorder—Raloxifene—breast cancer	0.000295	0.00796	CcSEcCtD
Icatibant—Injection site reaction—Docetaxel—breast cancer	0.000295	0.00795	CcSEcCtD
Icatibant—Injection site reaction—Capecitabine—breast cancer	0.000285	0.0077	CcSEcCtD
Icatibant—Body temperature increased—Exemestane—breast cancer	0.000282	0.00761	CcSEcCtD
Icatibant—Rash—Lapatinib—breast cancer	0.000282	0.0076	CcSEcCtD
Icatibant—Dermatitis—Lapatinib—breast cancer	0.000281	0.00759	CcSEcCtD
Icatibant—Headache—Lapatinib—breast cancer	0.00028	0.00755	CcSEcCtD
Icatibant—Dizziness—Fulvestrant—breast cancer	0.000272	0.00733	CcSEcCtD
Icatibant—Dizziness—Toremifene—breast cancer	0.000268	0.00723	CcSEcCtD
Icatibant—Body temperature increased—Ixabepilone—breast cancer	0.000266	0.00718	CcSEcCtD
Icatibant—Nausea—Lapatinib—breast cancer	0.000265	0.00716	CcSEcCtD
Icatibant—Hypersensitivity—Exemestane—breast cancer	0.000263	0.00709	CcSEcCtD
Icatibant—Rash—Fulvestrant—breast cancer	0.000259	0.00699	CcSEcCtD
Icatibant—Dermatitis—Fulvestrant—breast cancer	0.000259	0.00698	CcSEcCtD
Icatibant—Headache—Fulvestrant—breast cancer	0.000257	0.00694	CcSEcCtD
Icatibant—Rash—Toremifene—breast cancer	0.000256	0.0069	CcSEcCtD
Icatibant—Dermatitis—Toremifene—breast cancer	0.000255	0.00689	CcSEcCtD
Icatibant—Headache—Toremifene—breast cancer	0.000254	0.00685	CcSEcCtD
Icatibant—Body temperature increased—Letrozole—breast cancer	0.000251	0.00676	CcSEcCtD
Icatibant—Body temperature increased—Anastrozole—breast cancer	0.000251	0.00676	CcSEcCtD
Icatibant—Hypersensitivity—Ixabepilone—breast cancer	0.000248	0.00669	CcSEcCtD
Icatibant—Nausea—Fulvestrant—breast cancer	0.000244	0.00658	CcSEcCtD
Icatibant—Nausea—Toremifene—breast cancer	0.000241	0.0065	CcSEcCtD
Icatibant—Body temperature increased—Idarubicin—breast cancer	0.000238	0.00642	CcSEcCtD
Icatibant—Body temperature increased—Raloxifene—breast cancer	0.000238	0.00642	CcSEcCtD
Icatibant—Dizziness—Exemestane—breast cancer	0.000236	0.00637	CcSEcCtD
Icatibant—Hypersensitivity—Anastrozole—breast cancer	0.000234	0.0063	CcSEcCtD
Icatibant—Rash—Exemestane—breast cancer	0.000225	0.00607	CcSEcCtD
Icatibant—Dermatitis—Exemestane—breast cancer	0.000225	0.00606	CcSEcCtD
Icatibant—Headache—Exemestane—breast cancer	0.000224	0.00603	CcSEcCtD
Icatibant—Dizziness—Ixabepilone—breast cancer	0.000223	0.00601	CcSEcCtD
Icatibant—Hypersensitivity—Idarubicin—breast cancer	0.000222	0.00598	CcSEcCtD
Icatibant—Anaphylactic shock—Melphalan—breast cancer	0.000212	0.00573	CcSEcCtD
Icatibant—Rash—Ixabepilone—breast cancer	0.000212	0.00573	CcSEcCtD
Icatibant—Dermatitis—Ixabepilone—breast cancer	0.000212	0.00572	CcSEcCtD
Icatibant—Nausea—Exemestane—breast cancer	0.000212	0.00572	CcSEcCtD
Icatibant—Headache—Ixabepilone—breast cancer	0.000211	0.00569	CcSEcCtD
Icatibant—Dizziness—Anastrozole—breast cancer	0.00021	0.00566	CcSEcCtD
Icatibant—Dizziness—Letrozole—breast cancer	0.00021	0.00566	CcSEcCtD
Icatibant—Anaphylactic shock—Goserelin—breast cancer	0.000207	0.00559	CcSEcCtD
Icatibant—Nervous system disorder—Goserelin—breast cancer	0.000203	0.00548	CcSEcCtD
Icatibant—Nausea—Ixabepilone—breast cancer	0.0002	0.00539	CcSEcCtD
Icatibant—Rash—Letrozole—breast cancer	0.0002	0.00539	CcSEcCtD
Icatibant—Rash—Anastrozole—breast cancer	0.0002	0.00539	CcSEcCtD
Icatibant—Dermatitis—Anastrozole—breast cancer	0.0002	0.00539	CcSEcCtD
Icatibant—Dermatitis—Letrozole—breast cancer	0.0002	0.00539	CcSEcCtD
Icatibant—Dizziness—Raloxifene—breast cancer	0.000199	0.00537	CcSEcCtD
Icatibant—Injection site reaction—Epirubicin—breast cancer	0.000199	0.00536	CcSEcCtD
Icatibant—Headache—Anastrozole—breast cancer	0.000199	0.00536	CcSEcCtD
Icatibant—Headache—Letrozole—breast cancer	0.000199	0.00536	CcSEcCtD
Icatibant—Body temperature increased—Chlorambucil—breast cancer	0.000193	0.0052	CcSEcCtD
Icatibant—Rash—Raloxifene—breast cancer	0.00019	0.00512	CcSEcCtD
Icatibant—Rash—Idarubicin—breast cancer	0.00019	0.00512	CcSEcCtD
Icatibant—Dermatitis—Idarubicin—breast cancer	0.00019	0.00511	CcSEcCtD
Icatibant—Dermatitis—Raloxifene—breast cancer	0.00019	0.00511	CcSEcCtD
Icatibant—Headache—Raloxifene—breast cancer	0.000188	0.00509	CcSEcCtD
Icatibant—Headache—Idarubicin—breast cancer	0.000188	0.00509	CcSEcCtD
Icatibant—Nausea—Anastrozole—breast cancer	0.000188	0.00508	CcSEcCtD
Icatibant—Nausea—Letrozole—breast cancer	0.000188	0.00508	CcSEcCtD
Icatibant—Anaphylactic shock—Vinorelbine—breast cancer	0.000186	0.00501	CcSEcCtD
Icatibant—Injection site reaction—Doxorubicin—breast cancer	0.000184	0.00496	CcSEcCtD
Icatibant—Nervous system disorder—Vinorelbine—breast cancer	0.000182	0.00491	CcSEcCtD
Icatibant—Hypersensitivity—Chlorambucil—breast cancer	0.00018	0.00484	CcSEcCtD
Icatibant—Nausea—Idarubicin—breast cancer	0.000179	0.00482	CcSEcCtD
Icatibant—Nausea—Raloxifene—breast cancer	0.000179	0.00482	CcSEcCtD
Icatibant—Nervous system disorder—Thiotepa—breast cancer	0.000174	0.00469	CcSEcCtD
Icatibant—Hypersensitivity—Vinblastine—breast cancer	0.000165	0.00444	CcSEcCtD
Icatibant—Body temperature increased—Goserelin—breast cancer	0.000164	0.00442	CcSEcCtD
Icatibant—Hypersensitivity—Tamoxifen—breast cancer	0.00016	0.00431	CcSEcCtD
Icatibant—Hypersensitivity—Melphalan—breast cancer	0.000156	0.00422	CcSEcCtD
Icatibant—Anaphylactic shock—Mitoxantrone—breast cancer	0.000153	0.00413	CcSEcCtD
Icatibant—Anaphylactic shock—Irinotecan—breast cancer	0.000153	0.00413	CcSEcCtD
Icatibant—Hypersensitivity—Goserelin—breast cancer	0.000153	0.00412	CcSEcCtD
Icatibant—Nervous system disorder—Irinotecan—breast cancer	0.00015	0.00405	CcSEcCtD
Icatibant—Anaphylactic shock—Gemcitabine—breast cancer	0.000149	0.00402	CcSEcCtD
Icatibant—Dizziness—Vinblastine—breast cancer	0.000148	0.00398	CcSEcCtD
Icatibant—Body temperature increased—Vinorelbine—breast cancer	0.000147	0.00396	CcSEcCtD
Icatibant—Anaphylactic shock—Fluorouracil—breast cancer	0.000147	0.00395	CcSEcCtD
Icatibant—Nervous system disorder—Gemcitabine—breast cancer	0.000146	0.00394	CcSEcCtD
Icatibant—Nausea—Chlorambucil—breast cancer	0.000145	0.00391	CcSEcCtD
Icatibant—Nervous system disorder—Fluorouracil—breast cancer	0.000144	0.00388	CcSEcCtD
Icatibant—Dizziness—Tamoxifen—breast cancer	0.000143	0.00387	CcSEcCtD
Icatibant—Body temperature increased—Thiotepa—breast cancer	0.00014	0.00378	CcSEcCtD
Icatibant—Headache—Vinblastine—breast cancer	0.00014	0.00377	CcSEcCtD
Icatibant—Dizziness—Goserelin—breast cancer	0.000137	0.0037	CcSEcCtD
Icatibant—Rash—Tamoxifen—breast cancer	0.000137	0.00369	CcSEcCtD
Icatibant—Hypersensitivity—Vinorelbine—breast cancer	0.000137	0.00369	CcSEcCtD
Icatibant—Dermatitis—Tamoxifen—breast cancer	0.000137	0.00369	CcSEcCtD
Icatibant—Headache—Tamoxifen—breast cancer	0.000136	0.00367	CcSEcCtD
Icatibant—Rash—Melphalan—breast cancer	0.000134	0.00361	CcSEcCtD
Icatibant—Dermatitis—Melphalan—breast cancer	0.000134	0.00361	CcSEcCtD
Icatibant—Nausea—Vinblastine—breast cancer	0.000133	0.00358	CcSEcCtD
Icatibant—Rash—Goserelin—breast cancer	0.000131	0.00352	CcSEcCtD
Icatibant—Hypersensitivity—Thiotepa—breast cancer	0.000131	0.00352	CcSEcCtD
Icatibant—Dermatitis—Goserelin—breast cancer	0.000131	0.00352	CcSEcCtD
Icatibant—Headache—Goserelin—breast cancer	0.00013	0.0035	CcSEcCtD
Icatibant—Nausea—Tamoxifen—breast cancer	0.000129	0.00348	CcSEcCtD
Icatibant—Nausea—Melphalan—breast cancer	0.000126	0.0034	CcSEcCtD
Icatibant—Anaphylactic shock—Paclitaxel—breast cancer	0.000125	0.00337	CcSEcCtD
Icatibant—Nausea—Goserelin—breast cancer	0.000123	0.00332	CcSEcCtD
Icatibant—Dizziness—Vinorelbine—breast cancer	0.000123	0.00331	CcSEcCtD
Icatibant—Nervous system disorder—Paclitaxel—breast cancer	0.000122	0.0033	CcSEcCtD
Icatibant—Body temperature increased—Mitoxantrone—breast cancer	0.000121	0.00326	CcSEcCtD
Icatibant—Body temperature increased—Irinotecan—breast cancer	0.000121	0.00326	CcSEcCtD
Icatibant—Body temperature increased—Gemcitabine—breast cancer	0.000118	0.00318	CcSEcCtD
Icatibant—Dizziness—Thiotepa—breast cancer	0.000117	0.00316	CcSEcCtD
Icatibant—Rash—Vinorelbine—breast cancer	0.000117	0.00316	CcSEcCtD
Icatibant—Dermatitis—Vinorelbine—breast cancer	0.000117	0.00315	CcSEcCtD
Icatibant—Headache—Vinorelbine—breast cancer	0.000116	0.00314	CcSEcCtD
Icatibant—Body temperature increased—Fluorouracil—breast cancer	0.000116	0.00313	CcSEcCtD
Icatibant—Hypersensitivity—Irinotecan—breast cancer	0.000113	0.00304	CcSEcCtD
Icatibant—Hypersensitivity—Mitoxantrone—breast cancer	0.000113	0.00304	CcSEcCtD
Icatibant—Rash—Thiotepa—breast cancer	0.000112	0.00301	CcSEcCtD
Icatibant—Dermatitis—Thiotepa—breast cancer	0.000112	0.00301	CcSEcCtD
Icatibant—Headache—Thiotepa—breast cancer	0.000111	0.003	CcSEcCtD
Icatibant—Nausea—Vinorelbine—breast cancer	0.00011	0.00297	CcSEcCtD
Icatibant—Hypersensitivity—Fluorouracil—breast cancer	0.000108	0.00291	CcSEcCtD
Icatibant—Anaphylactic shock—Docetaxel—breast cancer	0.000106	0.00285	CcSEcCtD
Icatibant—Nausea—Thiotepa—breast cancer	0.000105	0.00284	CcSEcCtD
Icatibant—Nervous system disorder—Docetaxel—breast cancer	0.000104	0.0028	CcSEcCtD
Icatibant—Dizziness—Irinotecan—breast cancer	0.000101	0.00273	CcSEcCtD
Icatibant—Nervous system disorder—Capecitabine—breast cancer	0.0001	0.00271	CcSEcCtD
Icatibant—Body temperature increased—Paclitaxel—breast cancer	9.87e-05	0.00266	CcSEcCtD
Icatibant—Dizziness—Fluorouracil—breast cancer	9.69e-05	0.00262	CcSEcCtD
Icatibant—Rash—Mitoxantrone—breast cancer	9.65e-05	0.0026	CcSEcCtD
Icatibant—Rash—Irinotecan—breast cancer	9.65e-05	0.0026	CcSEcCtD
Icatibant—Dermatitis—Mitoxantrone—breast cancer	9.64e-05	0.0026	CcSEcCtD
Icatibant—Dermatitis—Irinotecan—breast cancer	9.64e-05	0.0026	CcSEcCtD
Icatibant—Headache—Irinotecan—breast cancer	9.59e-05	0.00259	CcSEcCtD
Icatibant—Headache—Mitoxantrone—breast cancer	9.59e-05	0.00259	CcSEcCtD
Icatibant—Rash—Gemcitabine—breast cancer	9.4e-05	0.00254	CcSEcCtD
Icatibant—Dermatitis—Gemcitabine—breast cancer	9.39e-05	0.00253	CcSEcCtD
Icatibant—Headache—Gemcitabine—breast cancer	9.34e-05	0.00252	CcSEcCtD
Icatibant—Rash—Fluorouracil—breast cancer	9.24e-05	0.00249	CcSEcCtD
Icatibant—Dermatitis—Fluorouracil—breast cancer	9.23e-05	0.00249	CcSEcCtD
Icatibant—Hypersensitivity—Paclitaxel—breast cancer	9.2e-05	0.00248	CcSEcCtD
Icatibant—Headache—Fluorouracil—breast cancer	9.18e-05	0.00248	CcSEcCtD
Icatibant—Nausea—Mitoxantrone—breast cancer	9.09e-05	0.00245	CcSEcCtD
Icatibant—Nausea—Irinotecan—breast cancer	9.09e-05	0.00245	CcSEcCtD
Icatibant—Nausea—Gemcitabine—breast cancer	8.86e-05	0.00239	CcSEcCtD
Icatibant—Nausea—Fluorouracil—breast cancer	8.71e-05	0.00235	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—EDNRB—breast cancer	8.6e-05	0.00122	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—BCL2—breast cancer	8.58e-05	0.00122	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—WNT10B—breast cancer	8.53e-05	0.00121	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—RPL23A—breast cancer	8.47e-05	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—MDM2—breast cancer	8.45e-05	0.0012	CbGpPWpGaD
Icatibant—Body temperature increased—Docetaxel—breast cancer	8.36e-05	0.00226	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CXCL3—breast cancer	8.31e-05	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL27—breast cancer	8.31e-05	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE2A—breast cancer	8.31e-05	0.00118	CbGpPWpGaD
Icatibant—Dizziness—Paclitaxel—breast cancer	8.25e-05	0.00223	CcSEcCtD
Icatibant—Body temperature increased—Capecitabine—breast cancer	8.1e-05	0.00218	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—RAF1—breast cancer	8.01e-05	0.00114	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—RPS8—breast cancer	7.9e-05	0.00112	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—RPS7—breast cancer	7.9e-05	0.00112	CbGpPWpGaD
Icatibant—Rash—Paclitaxel—breast cancer	7.87e-05	0.00212	CcSEcCtD
Icatibant—Dermatitis—Paclitaxel—breast cancer	7.86e-05	0.00212	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CB—breast cancer	7.83e-05	0.00111	CbGpPWpGaD
Icatibant—Headache—Paclitaxel—breast cancer	7.82e-05	0.00211	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CALCA—breast cancer	7.81e-05	0.00111	CbGpPWpGaD
Icatibant—Hypersensitivity—Docetaxel—breast cancer	7.79e-05	0.0021	CcSEcCtD
Icatibant—ANPEP—C-MYB transcription factor network—HRAS—breast cancer	7.63e-05	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCR4—breast cancer	7.63e-05	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL12—breast cancer	7.63e-05	0.00108	CbGpPWpGaD
Icatibant—Anaphylactic shock—Methotrexate—breast cancer	7.63e-05	0.00206	CcSEcCtD
Icatibant—Hypersensitivity—Capecitabine—breast cancer	7.55e-05	0.00204	CcSEcCtD
Icatibant—Nervous system disorder—Methotrexate—breast cancer	7.48e-05	0.00202	CcSEcCtD
Icatibant—Nausea—Paclitaxel—breast cancer	7.41e-05	0.002	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—JUN—breast cancer	7.35e-05	0.00104	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGFBP3—breast cancer	7.15e-05	0.00101	CbGpPWpGaD
Icatibant—Anaphylactic shock—Epirubicin—breast cancer	7.14e-05	0.00193	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—CDKN1A—breast cancer	7.12e-05	0.00101	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—PTEN—breast cancer	7.11e-05	0.00101	CbGpPWpGaD
Icatibant—Nervous system disorder—Epirubicin—breast cancer	7e-05	0.00189	CcSEcCtD
Icatibant—Dizziness—Docetaxel—breast cancer	7e-05	0.00189	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—ACHE—breast cancer	6.98e-05	0.000991	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR1—breast cancer	6.9e-05	0.000979	CbGpPWpGaD
Icatibant—Dizziness—Capecitabine—breast cancer	6.77e-05	0.00183	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—RGS2—breast cancer	6.69e-05	0.000949	CbGpPWpGaD
Icatibant—Rash—Docetaxel—breast cancer	6.67e-05	0.0018	CcSEcCtD
Icatibant—Dermatitis—Docetaxel—breast cancer	6.66e-05	0.0018	CcSEcCtD
Icatibant—Headache—Docetaxel—breast cancer	6.63e-05	0.00179	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CCL20—breast cancer	6.62e-05	0.000939	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CTSD—breast cancer	6.61e-05	0.000938	CbGpPWpGaD
Icatibant—Anaphylactic shock—Doxorubicin—breast cancer	6.6e-05	0.00178	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—THBS1—breast cancer	6.51e-05	0.000924	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LGR6—breast cancer	6.48e-05	0.000919	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCDC88C—breast cancer	6.48e-05	0.000919	CbGpPWpGaD
Icatibant—Nervous system disorder—Doxorubicin—breast cancer	6.48e-05	0.00175	CcSEcCtD
Icatibant—Rash—Capecitabine—breast cancer	6.46e-05	0.00174	CcSEcCtD
Icatibant—Dermatitis—Capecitabine—breast cancer	6.45e-05	0.00174	CcSEcCtD
Icatibant—Headache—Capecitabine—breast cancer	6.42e-05	0.00173	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—LPAR1—breast cancer	6.41e-05	0.000909	CbGpPWpGaD
Icatibant—Nausea—Docetaxel—breast cancer	6.28e-05	0.0017	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—breast cancer	6.19e-05	0.000878	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SFRP1—breast cancer	6.18e-05	0.000877	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GPER1—breast cancer	6.18e-05	0.000877	CbGpPWpGaD
Icatibant—Nausea—Capecitabine—breast cancer	6.08e-05	0.00164	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—BCHE—breast cancer	6.08e-05	0.000863	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RGS2—breast cancer	6.08e-05	0.000862	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PDE4D—breast cancer	6.05e-05	0.000859	CbGpPWpGaD
Icatibant—Body temperature increased—Methotrexate—breast cancer	6.03e-05	0.00163	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCL20—breast cancer	6.01e-05	0.000852	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	5.98e-05	0.000848	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—RPS6—breast cancer	5.94e-05	0.000842	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NMBR—breast cancer	5.93e-05	0.000841	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR2—breast cancer	5.9e-05	0.000837	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—LPAR1—breast cancer	5.82e-05	0.000826	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—MAPK3—breast cancer	5.78e-05	0.00082	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EGFR—breast cancer	5.78e-05	0.00082	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—TCF7L2—breast cancer	5.66e-05	0.000803	CbGpPWpGaD
Icatibant—Body temperature increased—Epirubicin—breast cancer	5.64e-05	0.00152	CcSEcCtD
Icatibant—Hypersensitivity—Methotrexate—breast cancer	5.62e-05	0.00152	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HEYL—breast cancer	5.51e-05	0.000781	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CUL5—breast cancer	5.51e-05	0.000781	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGER1—breast cancer	5.51e-05	0.000781	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE4D—breast cancer	5.5e-05	0.00078	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGFR—breast cancer	5.5e-05	0.00078	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR2—breast cancer	5.36e-05	0.00076	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLAUR—breast cancer	5.29e-05	0.000751	CbGpPWpGaD
Icatibant—Hypersensitivity—Epirubicin—breast cancer	5.26e-05	0.00142	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—breast cancer	5.22e-05	0.000741	CbGpPWpGaD
Icatibant—Body temperature increased—Doxorubicin—breast cancer	5.22e-05	0.00141	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—KRAS—breast cancer	5.19e-05	0.000737	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RSPO3—breast cancer	5.18e-05	0.000735	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLG—breast cancer	5.17e-05	0.000734	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR2—breast cancer	5.07e-05	0.000719	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL2—breast cancer	5.07e-05	0.000719	CbGpPWpGaD
Icatibant—Dizziness—Methotrexate—breast cancer	5.04e-05	0.00136	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—WWOX—breast cancer	5.04e-05	0.000715	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—WNT10B—breast cancer	5.04e-05	0.000715	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—WNT1—breast cancer	5.04e-05	0.000714	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTHLH—breast cancer	5.02e-05	0.000711	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—INHBB—breast cancer	4.91e-05	0.000697	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE2A—breast cancer	4.91e-05	0.000697	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL3—breast cancer	4.91e-05	0.000697	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL27—breast cancer	4.91e-05	0.000697	CbGpPWpGaD
Icatibant—Hypersensitivity—Doxorubicin—breast cancer	4.86e-05	0.00131	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRB—breast cancer	4.86e-05	0.000689	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TP53—breast cancer	4.85e-05	0.000688	CbGpPWpGaD
Icatibant—Rash—Methotrexate—breast cancer	4.81e-05	0.0013	CcSEcCtD
Icatibant—Dermatitis—Methotrexate—breast cancer	4.8e-05	0.0013	CcSEcCtD
Icatibant—Headache—Methotrexate—breast cancer	4.78e-05	0.00129	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CA—breast cancer	4.77e-05	0.000677	CbGpPWpGaD
Icatibant—Dizziness—Epirubicin—breast cancer	4.72e-05	0.00127	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—BMPR2—breast cancer	4.68e-05	0.000664	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DLL4—breast cancer	4.68e-05	0.000664	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL2—breast cancer	4.61e-05	0.000653	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR2—breast cancer	4.61e-05	0.000653	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTHLH—breast cancer	4.55e-05	0.000646	CbGpPWpGaD
Icatibant—Nausea—Methotrexate—breast cancer	4.53e-05	0.00122	CcSEcCtD
Icatibant—Rash—Epirubicin—breast cancer	4.5e-05	0.00121	CcSEcCtD
Icatibant—Dermatitis—Epirubicin—breast cancer	4.5e-05	0.00121	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CDH5—breast cancer	4.49e-05	0.000637	CbGpPWpGaD
Icatibant—Headache—Epirubicin—breast cancer	4.47e-05	0.00121	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CALCA—breast cancer	4.42e-05	0.000626	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDNRB—breast cancer	4.41e-05	0.000626	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SFRP2—breast cancer	4.4e-05	0.000625	CbGpPWpGaD
Icatibant—Dizziness—Doxorubicin—breast cancer	4.37e-05	0.00118	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PRLR—breast cancer	4.32e-05	0.000613	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCR4—breast cancer	4.31e-05	0.000612	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL12—breast cancer	4.31e-05	0.000612	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	4.31e-05	0.000611	CbGpPWpGaD
Icatibant—Nausea—Epirubicin—breast cancer	4.24e-05	0.00114	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—GLI2—breast cancer	4.18e-05	0.000592	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VCP—breast cancer	4.18e-05	0.000592	CbGpPWpGaD
Icatibant—Rash—Doxorubicin—breast cancer	4.16e-05	0.00112	CcSEcCtD
Icatibant—Dermatitis—Doxorubicin—breast cancer	4.16e-05	0.00112	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	4.15e-05	0.000589	CbGpPWpGaD
Icatibant—Headache—Doxorubicin—breast cancer	4.14e-05	0.00112	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—LEPR—breast cancer	4.11e-05	0.000583	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	4.1e-05	0.000581	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CALCA—breast cancer	4.01e-05	0.000569	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—PIK3CA—breast cancer	3.98e-05	0.000564	CbGpPWpGaD
Icatibant—Nausea—Doxorubicin—breast cancer	3.92e-05	0.00106	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CXCL12—breast cancer	3.92e-05	0.000556	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCR4—breast cancer	3.92e-05	0.000556	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR1—breast cancer	3.9e-05	0.000553	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	3.87e-05	0.000549	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ARHGDIA—breast cancer	3.82e-05	0.000542	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP1—breast cancer	3.78e-05	0.000537	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FST—breast cancer	3.72e-05	0.000528	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HEY2—breast cancer	3.68e-05	0.000521	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—breast cancer	3.66e-05	0.000519	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RPS6KB2—breast cancer	3.63e-05	0.000515	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RGS2—breast cancer	3.59e-05	0.000509	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	3.56e-05	0.000505	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL20—breast cancer	3.55e-05	0.000504	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR1—breast cancer	3.54e-05	0.000502	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ITPR1—breast cancer	3.5e-05	0.000496	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TLE3—breast cancer	3.44e-05	0.000488	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LPAR1—breast cancer	3.44e-05	0.000488	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HEY1—breast cancer	3.4e-05	0.000483	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DLL1—breast cancer	3.34e-05	0.000473	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	3.29e-05	0.000467	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HIST1H2BK—breast cancer	3.28e-05	0.000465	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HIST1H2BC—breast cancer	3.28e-05	0.000465	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE4D—breast cancer	3.25e-05	0.000461	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRB7—breast cancer	3.25e-05	0.000461	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CSF2—breast cancer	3.23e-05	0.000458	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TAB2—breast cancer	3.19e-05	0.000453	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ITPR1—breast cancer	3.18e-05	0.000451	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR2—breast cancer	3.16e-05	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—breast cancer	3.16e-05	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MMP3—breast cancer	3.16e-05	0.000448	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	3.15e-05	0.000447	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DKK1—breast cancer	3.09e-05	0.000438	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFC—breast cancer	3.06e-05	0.000435	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGF1—breast cancer	3.02e-05	0.000429	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAG2—breast cancer	3.02e-05	0.000428	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—WNT1—breast cancer	2.97e-05	0.000422	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PLA2G4A—breast cancer	2.97e-05	0.000421	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CSF2—breast cancer	2.93e-05	0.000416	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP2—breast cancer	2.93e-05	0.000415	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH4—breast cancer	2.82e-05	0.0004	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GZMB—breast cancer	2.8e-05	0.000398	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL2—breast cancer	2.72e-05	0.000386	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR2—breast cancer	2.72e-05	0.000386	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTHLH—breast cancer	2.69e-05	0.000382	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—BMP2—breast cancer	2.69e-05	0.000382	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDNRB—breast cancer	2.61e-05	0.00037	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PGR—breast cancer	2.58e-05	0.000366	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—THBS1—breast cancer	2.57e-05	0.000364	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FLT1—breast cancer	2.45e-05	0.000348	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGF3—breast cancer	2.44e-05	0.000346	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SQSTM1—breast cancer	2.44e-05	0.000346	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—breast cancer	2.43e-05	0.000345	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CG—breast cancer	2.43e-05	0.000344	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAG1—breast cancer	2.41e-05	0.000342	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PARP1—breast cancer	2.4e-05	0.00034	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH3—breast cancer	2.4e-05	0.00034	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CALCA—breast cancer	2.37e-05	0.000336	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RPS6—breast cancer	2.34e-05	0.000332	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGF4—breast cancer	2.32e-05	0.000329	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCR4—breast cancer	2.31e-05	0.000328	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL12—breast cancer	2.31e-05	0.000328	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PAK1—breast cancer	2.27e-05	0.000322	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CTNNB1—breast cancer	2.24e-05	0.000318	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TCF7L2—breast cancer	2.23e-05	0.000316	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT2—breast cancer	2.22e-05	0.000315	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CG—breast cancer	2.2e-05	0.000313	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH2—breast cancer	2.15e-05	0.000305	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HSP90AA1—breast cancer	2.15e-05	0.000305	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CD—breast cancer	2.13e-05	0.000303	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRL—breast cancer	2.09e-05	0.000297	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR1—breast cancer	2.09e-05	0.000297	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STK11—breast cancer	2.06e-05	0.000293	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADAM10—breast cancer	2.06e-05	0.000293	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLG—breast cancer	2.04e-05	0.000289	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT2—breast cancer	2.02e-05	0.000286	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGF10—breast cancer	2.01e-05	0.000285	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CD—breast cancer	1.94e-05	0.000275	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDGFA—breast cancer	1.94e-05	0.000275	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFBR2—breast cancer	1.91e-05	0.000271	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ITPR1—breast cancer	1.88e-05	0.000266	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ERBB4—breast cancer	1.86e-05	0.000265	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT5A—breast cancer	1.86e-05	0.000265	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP3—breast cancer	1.86e-05	0.000265	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CB—breast cancer	1.86e-05	0.000264	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SMAD4—breast cancer	1.81e-05	0.000256	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF1R—breast cancer	1.8e-05	0.000255	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—breast cancer	1.79e-05	0.000253	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HES1—breast cancer	1.76e-05	0.00025	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLA2G4A—breast cancer	1.75e-05	0.000249	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NCOR1—breast cancer	1.75e-05	0.000249	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CSF2—breast cancer	1.73e-05	0.000246	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGF1—breast cancer	1.73e-05	0.000246	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RAF1—breast cancer	1.73e-05	0.000245	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NRG1—breast cancer	1.72e-05	0.000244	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—H2AFX—breast cancer	1.71e-05	0.000242	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2—breast cancer	1.71e-05	0.000242	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—E2F1—breast cancer	1.7e-05	0.000241	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CB—breast cancer	1.69e-05	0.00024	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SPP1—breast cancer	1.63e-05	0.000231	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—breast cancer	1.62e-05	0.00023	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ERBB3—breast cancer	1.61e-05	0.000229	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGFR2—breast cancer	1.61e-05	0.000228	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2—breast cancer	1.55e-05	0.00022	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TERT—breast cancer	1.55e-05	0.000219	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGFR1—breast cancer	1.5e-05	0.000213	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HIF1A—breast cancer	1.48e-05	0.00021	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEP—breast cancer	1.44e-05	0.000205	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CAV1—breast cancer	1.43e-05	0.000203	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KDR—breast cancer	1.41e-05	0.0002	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ESR1—breast cancer	1.38e-05	0.000195	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FN1—breast cancer	1.36e-05	0.000193	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFKBIA—breast cancer	1.34e-05	0.000191	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH1—breast cancer	1.33e-05	0.000189	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APC—breast cancer	1.3e-05	0.000185	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3CG—breast cancer	1.3e-05	0.000185	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KIT—breast cancer	1.3e-05	0.000185	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGF—breast cancer	1.29e-05	0.000183	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MAPK3—breast cancer	1.25e-05	0.000177	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—BRAF—breast cancer	1.22e-05	0.000174	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF1—breast cancer	1.19e-05	0.000169	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT2—breast cancer	1.19e-05	0.000169	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EGFR—breast cancer	1.19e-05	0.000168	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3CD—breast cancer	1.14e-05	0.000162	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.13e-05	0.000161	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SERPINE1—breast cancer	1.13e-05	0.000161	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—KRAS—breast cancer	1.12e-05	0.000159	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—breast cancer	1.08e-05	0.000153	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CA—breast cancer	1.03e-05	0.000146	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MDM2—breast cancer	1.03e-05	0.000145	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RAF1—breast cancer	1.02e-05	0.000145	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RELA—breast cancer	1.02e-05	0.000144	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ERBB2—breast cancer	1.01e-05	0.000143	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MTOR—breast cancer	9.98e-06	0.000142	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3CB—breast cancer	9.98e-06	0.000142	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—breast cancer	9.59e-06	0.000136	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HRAS—breast cancer	9.52e-06	0.000135	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CDKN1B—breast cancer	9.36e-06	0.000133	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT1—breast cancer	9.26e-06	0.000131	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CASP3—breast cancer	9.18e-06	0.00013	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2—breast cancer	9.16e-06	0.00013	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—breast cancer	9.12e-06	0.000129	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCND1—breast cancer	8.93e-06	0.000127	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JUN—breast cancer	8.91e-06	0.000126	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CTNNB1—breast cancer	8.84e-06	0.000125	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—breast cancer	8.67e-06	0.000123	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CDKN1A—breast cancer	8.64e-06	0.000123	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTEN—breast cancer	8.62e-06	0.000122	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MAPK8—breast cancer	8.43e-06	0.00012	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT1—breast cancer	8.41e-06	0.000119	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SRC—breast cancer	7.99e-06	0.000113	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—breast cancer	7.79e-06	0.00011	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT3—breast cancer	7.71e-06	0.000109	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MAPK3—breast cancer	7.37e-06	0.000104	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MYC—breast cancer	7.16e-06	0.000102	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—breast cancer	7.15e-06	0.000101	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGFR—breast cancer	7.01e-06	9.94e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KRAS—breast cancer	6.62e-06	9.39e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3CA—breast cancer	6.08e-06	8.63e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TP53—breast cancer	5.88e-06	8.35e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRAS—breast cancer	5.63e-06	7.98e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—breast cancer	5.39e-06	7.64e-05	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT1—breast cancer	4.97e-06	7.05e-05	CbGpPWpGaD
